Skip to content

A comparative study on clinical outcomes of streptokinase therapy in diabetic and Non diabetic Patients

A comparative study on clinical outcomes of streptokinase therapy in diabetic and Non diabetic Patients - CSOCOST-DANDP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102528
Enrollment
90
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: I213- ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention1: Nil: Nil

Sponsors

ICMR-STS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirm STEMI,treated with streptokinase therapy for myocardial infraction as per hospital protocol and voluntary giving inform concent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
not formulatedTimepoint:

Primary

MeasureTime frame
Successful thrombosis,more than 50% ST segment resolution on ECG.Timepoint: Within 90 minutes of thrombolysis therapy

Countries

India

Contacts

Public ContactAparna Zala

Parul institute of medical sciences and research

muleyarti40@gmail.com9879609196

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026